Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices
Abstract Background Cyclophosphamide (CYC) is an inactive alkylating agent that transforms the alkyl radicals into other molecules and is used in combination with systemic corticosteroids in the treatment of many childhood rheumatic diseases, such as systemic lupus erythematosus (SLE), and ANCA-asso...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-03-01
|
| Colecção: | Pediatric Rheumatology Online Journal |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12969-025-01080-9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
